|[October 14, 2013]
Research and Markets: Polio Global Clinical Trials Review - New 2013 Report
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/m6zlch/polio_global)
has announced the addition of the "Polio
Global Clinical Trials Review, H2, 2013" report to their
"Polio Global Clinical Trials Review, H2, 2013" provides data on the
Polio clinical trial scenario. This report provides elemental
information and data relating to the clinical trials on Polio. It
includes an overview of the trial numbers and their recruitment status
as per the site of trial conduction across the globe. The databook
offers a preliminary coverage of disease clinical trials bytheir phase,
trial status, prominence of the sponsors and also provides briefing
pertaining to the number of trials for the key drugs for treating Polio.
Data on the number of clinical trials conducted in North America,
South and Central America, Europe, Middle-East and Africa and
Asia-Pacific and top five national contributions in each, along with
the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status,
subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Top Companies Participating in Polio Therapeutics Clinical Trials
Bharat Biotech International Limited
Biolab Sanus Farmaceutica Ltda.
Daiichi Sankyo Company, Limited
Laboratorios de Biologicos y Reactivos de Mexico, S.A de C.V.
Merck & Co., Inc.
Mitsubishi (News - Alert) Tanabe Pharma Corporation
Panacea Biotec Limited
Statens Serum Institut
Takeda Pharmaceutical Company Limited
For more information visit http://www.researchandmarkets.com/research/m6zlch/polio_global
[ Back To Technology News's Homepage ]